Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine Candidate Into Clinical Trials

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/39S9EiO
via IFTTT